Clinical trial
Development of Adaptive Deep Brain Stimulation (aDBS) for the Treatment of Intractable OCD: Phase Ib Using Summit RC+S
NCT04281134 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Adaptive Deep Brain Stimulation (aDBS) for the Treatment of Intractable OCD: Phase Ib Using Summit RC+S
- Lead sponsor
- Baylor College of Medicine
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 11, 2019
- Completion date
- June 30, 2027
- Enrollment
- 3 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.